Cybulska-Stopa B, Piejko K, Ostaszewski K, Dziura R, et al. Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment. Melanoma Res 2023 Apr 3. doi: 10.1097/CMR.0000000000000885.
PMID: 37015054